Overview
Watchlist
Equities
Crypto
Soon
Popular
Cookies
Terms of Service
Privacy Policy
Home
© 2026 FYStats. 
Home
Equities
NAMS
Fundamentals

Newamsterdam Pharma Co N.v.

NAMS

Chart
Fundamentals
Soon
Sentiment
Soon
Options

Revenue

32.00k
▼-316.00k▼-90.80%
3 Months Change

Assets

471.10M
▼-60.49M▼-11.38%
6 Months Change

Liabilities

85.85M
▲27.50M▲47.12%
3 Months Change

Free Cash Flow

-36.48M
▲18.50M▲33.65%
12 Months Change

Revenue/Cost Of Revenue

Loading...

Net Profit/Loss

Loading...

Assets/Liabilities

Loading...

Cash Flows

Loading...

Earnings Per Share

Loading...

Outstanding Shares

Loading...

Recent Quarterly and Annual Filings

2026-03-02
Form 8-K
ID: 0001193125-26-084266
2026-02-18
Form 8-K
ID: 0001193125-26-056020
2026-01-09
Form 8-K
ID: 0001193125-26-008300
2025-11-05
Form 10-Q
ID: 0001193125-25-265796
2025-11-05
Form 8-K
ID: 0001193125-25-265800
2025-09-02
Form 8-K
ID: 0000950170-25-112345
2025-08-18
Form 8-K
ID: 0000950170-25-109567
2025-08-15
Form 8-K
ID: 0000950170-25-109387
2025-08-06
Form 8-K
ID: 0000950170-25-103520
2025-08-06
Form 10-Q
ID: 0000950170-25-103521